Ma

mAbs

mAbs is a multidisciplinary open access journal dedicated to antibody research and development. It covers topics including engineering and selection of antibody therapeutics, machine learning and artificial intelligence applications, non-clinical antibody studies, manufacturing and formulation, regulatory review of antibody therapeutics, and post-approval market topics, and serves scientific, medical, technology transfer, legal, investment, planning, and therapeutics regulation audiences.

Looking to publish in mAbs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Medicine, Research & Experimental
Impact Factor 7.3
Quartile Q1
Open Access Type Hybrid
ISSN 1942-0862
eISSN 1942-0870
Invitation Only No
Cost Range Open access publication may be covered by an institutional open access agreement; specific APC amounts are not stated.

Submission Instructions

mAbs accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A single-paragraph abstract is required for Research Articles. The abstract must be fewer than 250 words. The abstract must be unstructured as a single paragraph.
Manuscript Research Articles must include Introduction, Patients and Methods or Materials and Methods, Results, and Discussion sections. Manuscripts must include 5 to 10 keywords, a disclosure statement under the subheading “Disclosure of interest,” and figure legends.
References Research Articles must include no more than 85 references. References may be in any consistent scholarly citation style or format. Bibliographic entries must include author name(s), source title, article or chapter title, year, volume and issue where appropriate, page numbers, and a corresponding in-text citation.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents. Tables must be numbered consecutively with Arabic numerals and include descriptive titles and legends.
Reformat to mAbs using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be 150 words.
Manuscript The opening paragraph must explain the review’s general thrust and timeliness, and the concluding paragraph must discuss future developments or problems rather than summarize the article. The manuscript must include 5–10 keywords for indexing purposes.
References Reviews must cite no more than 150 references. References may be in any style or format if a consistent scholarly citation format is used. Bibliographic entries must include the author name(s), article or chapter title, journal or book title, year, volume and issue where appropriate, page numbers, and a corresponding in-text citation.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents.
Reformat to mAbs using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract A one-paragraph abstract is required for Brief Reports. Abstract must be fewer than 150 words. Abstract must be unstructured as a single paragraph.
Manuscript Manuscripts must include 5 to 10 keywords, a disclosure statement under the subheading “Disclosure of interest,” and a word count for the paper.
References References may be in any style or format if a consistent scholarly citation format is used. References must include complete bibliographic details and each entry must have a corresponding in-text citation.
Figures & Tables Figures and tables may be placed within the text or submitted as separate documents.
Reformat to mAbs using Livewrite Premium

Short Communications

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required for Short Communications. Abstract must not exceed 120 words. Abstract structure is not specified.
Manuscript Manuscript must not exceed 4,500 words in total. Short Communications must follow the structure of a Research Article but without headings or subheadings. Manuscript must include 5 to 10 keywords and a disclosure statement under the subheading “Disclosure of interest.”
References Short Communications must include no more than 50 references. References may be submitted in any consistent scholarly citation style or format. Bibliographic entries must include the relevant publication details and each entry must have a corresponding in-text citation.
Figures & Tables Figures and tables may be embedded within the text or submitted as separate documents.
Reformat to mAbs using Livewrite Premium

Recent Publications

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens

Martin Hofmann, Felix Unverdorben, M. Gabriele Pszolla, Nadine Aschmoneit, Meike Hutt, Timo Manz, Heiko Schuster, Jens Hukelmann, Andreas Acs, Clara Tenkerian, Sarah Missel, Michael Mølhøj, Christoph Schräder, Claudia Wagner, Dominik Maurer, Sebastian Bunk, Carsten Reinhardt

10.1080/19420862.2026.2722707
View Publication

Antibody framework engineering enables augmented cytokine receptor signaling capacities of bispecific single domain antibody-based IL-21 mimetics

Britta Lipinski, Laura Unmuth, Thi Hong Hue Tran, Jakob Harwood, Paul Arras, Stefan Becker, Julia Harwardt, Enrico Guarnera, Laura Helming, Rinat Zaynagetdinov, Davide Bertoldo, Arvind Rajpal, Desislava Elter, Lukas Pekar, Andreas Evers, Stefan Zielonka

10.1080/19420862.2026.2726042
View Publication

Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers

Yang Liu, Hongsen Peng, Xing Fan, Xiaoxi Liu, Guanda Jiao, Jialin Li, Tiantian Wang, Simon James Fong, Lipeng Zhu, Yeneng Dai, Qi Zhao

10.1080/19420862.2026.2717991
View Publication

Quantifying molecular specificity in excipient-driven antibody solubilization

Zexiang Han, Nadia A. Erkamp, Rob Scrutton, Giuseppe Licari, Olga Predeina, Andreas Evers, Pietro Sormanni, Tuomas P. J. Knowles

10.1080/19420862.2026.2722444
View Publication

DyAb: sequence-based antibody design and property prediction in a low-data regime

Joshua Yao-Yu Lin, Jennifer L. Hofmann, Andrew Leaver-Fay, Wei-Ching Liang, Stefania Vasilaki, Edith Lee, Pedro O. Pinheiro, Natasa Tagasovska, James R. Kiefer, Yan Wu, Franziska Seeger, Richard Bonneau, Vladimir Gligorijevic, Andrew Watkins, Kyunghyun Cho, Nathan Frey

10.1080/19420862.2026.2717460
View Publication

Frequently asked questions

How long does it take to publish?

13 days average from submission to first decision; 27 days average from submission to first post-review decision; 11 days average from acceptance to online publication.

Reformat to mAbs using Livewrite Premium

What are the publication costs?

Open access publication may be covered by an institutional open access agreement; specific APC amounts are not stated.

Reformat to mAbs using Livewrite Premium

Research Topics

Monoclonal and Polyclonal Antibodies Research Protein purification and stability Glycosylation and Glycoproteins Research Viral Infectious Diseases and Gene Expression in Insects Biosimilars and Bioanalytical Methods CAR-T cell therapy research T-cell and B-cell Immunology HER2/EGFR in Cancer Research Immunotherapy and Immune Responses Immune Cell Function and Interaction Transgenic Plants and Applications Chronic Lymphocytic Leukemia Research vaccines and immunoinformatics approaches Galectins and Cancer Biology Toxin Mechanisms and Immunotoxins Advanced Biosensing Techniques and Applications Cell Adhesion Molecules Research Immunodeficiency and Autoimmune Disorders Cancer Immunotherapy and Biomarkers SARS-CoV-2 and COVID-19 Research Complement system in diseases Mass Spectrometry Techniques and Applications Peptidase Inhibition and Analysis Lymphoma Diagnosis and Treatment Nanofabrication and Lithography Techniques

Related Journals

Am
Amyloid Taylor & Francis
JO
Journal of Molecular Medicine Springer Science+Business Media
EM
EMBO Molecular Medicine Springer Nature
JO
Journal of Diabetes Research Hindawi Publishing Corporation
OJ
Orphanet Journal of Rare Diseases BioMed Central
EJ
European Journal of Clinical Investigation WILEY